Lipids, Lipoproteins, and Drugs [electronic resource] /

Opening Remarks -- Chemistry and Physiology of Lipoproteins -- The Interaction of Apolipoprotein-Alanine (ApoC-III) with Lipids: Study of Structural Features Required for Binding -- Lipoproteins and Lipid Transport -- Pathways of Lipoprotein Metabolism: Integration of Structure, Function and Metabolism -- Steroid Requirements for Suppression of HMG-CoA Reductase Activity in Cultured Human Fibroblasts -- The Immunology of Serum Lipoproteins -- Biochemical Pharmacology of Hypolipidemic Drugs -- Hormone-Induced Lipolysis and the Metabolic Pathways Providing Energy to the Cell: A Possible Role of ATP as a Rate-Limiting Factor -- Mechanism of Action of Hypolipidemic Drugs -- Newer Hypolipidemic Compounds -- Experimental and Clinical Evaluation of Two “Atromid-S” Analogues in Relation to Their Differential Modes of Action -- Approaches to Treatment of Hyperlipidemias -- Pathogenesis of Hyperlipidemias, Clues to Treatment? -- Serum Lipoprotein Composition in Different Types of Hyperlipoproteinemia -- Diet in the Management of Hyperlipidemic Patients -- The Partial Ileal Bypass Operation in Treatment of the Hyperlipidemias -- Drugs and Thrombosis -- The Activation and Inhibition of Fibrinolysis -- The Role of Lipids in the Tissue Factor Pathway of Blood Coagulation -- Use of Fibrinopeptide A Measurements in the Diagnosis and Management of Thrombosis -- Modifications of Platelet Functions by Dietary Fats -- Risk Factors Other than Diet -- Diabetes as a Risk Factor for Arteriosclerotic Vascular Disease -- Hypertension and Other Risk Factors -- The Heritable Hyperlipoproteinemias and Atherosclerosis -- Smoking and Carbon Monoxide Uptake as a Risk Factor in Atherosclerotic Cardiovascular Disease -- Risk of Coronary Disease and Coronary Complications by Neural and Psychological Factors -- Animal Models for Atherosclerosis Research -- New Animal Model for Atherosclerosis Research -- Effects of Various Hypolipidemic Drugs on Fatty Acid Composition of Liver and Serum Lipids -- Some Aspects of the Chimpanzee as a Model for Experimental Atherosclerosis -- Studies on Experimental Atherosclerosis by Immunofluorescence -- The Effects of Tolbutamide on the Development of Atherosclerosis in Rhesus Monkeys Fed an Average American Table-Prepared Diet -- The Cockerel as an Animal Model for Atherosclerosis Research -- Influence of Platelets on the Integrity of the Vessel Wall -- Scope and Organization of a Lipid Clinic and Clinical Trials -- Scope and Organization of a Lipid Clinic and Clinical Trials -- Portacaval Shunt in Two Patients with Homozygous Hypercholesterolemia -- Planning the Type II Coronary Primary Prevention Trial of the Lipid Research Clinics (U. S. A.) -- Concluding Remarks -- Abstracts of Submitted Papers -- Author Index.

Bibliographic Details

Main Authors:	Kritchevsky, David. editor., Paoletti, Rodolfo. editor., Holmes, William L. editor., SpringerLink (Online service)
Format:	Texto biblioteca
Language:	eng
Published:	Boston, MA : Springer US, 1975
Subjects:	Medicine., Pharmacology., Biomedicine., Pharmacology/Toxicology.,
Online Access:	http://dx.doi.org/10.1007/978-1-4684-3258-9
Tags:	Add Tag No Tags, Be the first to tag this record!